Pharma's Almanac

5840 Articles Available

0 244

FDA Approval

Possible New Hope for Metastatic Cancer Patients: Food and Drug Administration Grants Approval for Clinical Trials For Lamassu's Groundbreaking Cancer Treatment Protocol

PR-M04-24-01

Down Stream Processing

Expediting Biologics Drug Development: Downstream Strategies to Accelerate Preclinical Development Timelines

PAO-04-24-CL-05

Microfluidics

How Microfluidic Devices are Benefitting Biopharmaceutical Development and Manufacturing

PAO-04-24-NI-02

mRNA Innovations

Technology Advances Needed to Drive Future mRNA Growth

PAO-04-24-CL-04

Cell and Gene Therapy Regulatory

Navigating Regulatory Complexity for Cell and Gene Therapies

mRNA Manufacturing

Navigating mRNA Manufacturing with Flexibility and Innovation

PAO-04-24-CL-02

Nice Insight Reports

Biotech Funding Ups and Downs

PAO-04-24-NI-01

pDNA Manufacturing

Overcoming pDNA Supply Challenges for mRNA Manufacturing

PAO-04-24-CL-01

ESG

Leading CDMO PCI Pharma Services Releases Inaugural Comprehensive ESG Report

PR-M03-24-04

Outsourced Manufacturing

A Closer Look at Small Molecule Drug Substance and Drug Product Manufacturing

PAO-03-24-NI-02

IND, NDA, and BLA

Building a Regulatory Roadmap for IND, NDA, and BLA

PAO-03-24-CL-10

Nice Insight API Report

Small Molecule API Discovery and Development Trends

PAO-03-24-NI-01

mRNA–LNP Manufacturing

The Innovators Bringing Continuous Manufacturing to Lipid Nanoparticles

PAO-03-24-CL-08

Radioconjugate development

Expediting Radioimmune Conjugate Pharmaceuticals for First-In-Human Phase 0 Proof-of-Concept Human Studies from Stable Pool

PAO-03-24-CL-07

Lead Share Agreement

List Biotherapeutics and Sacco System Announce Lead Share Agreement

PR-M03-24-03

Viral Vectors

A Viral Vector CDMO Vision that Resonates

PAO-03-24-CL-06

Analytical Method Development

Harnessing Biologic Development Experience in Support of CDMO Clients: Rapid, Effective and Tailored Analytical Method Development

PAO-03-24-CL-09

Biomanufacturing

Antheia and Olon Continue Partnership for Biomanufacturing Antheia’s Pipeline of KSMs and APIs for Essential Medicines

PR-M03-24-02

Clinical Trials Representation

Leveraging Decentralized Clinical Trial Strategies to Reduce Health Care Disparities

PAO-03-24-CL-05

Commitment to ESG Principles

How can pharmaceutical and biopharmaceutical companies demonstrate their commitment to ESG principles in manufacturing?

PAO-03-24-CL-03

Accelerating Product Development

What strategies are being employed to accelerate product development and commercialization without compromising quality?

PAO-03-24-CL-02

Manufacturing Partnership

Genezen Announces Strategic Process Development and Manufacturing Partnership Agreement with Seattle Children’s Research Institute for X-linked Agammaglobulinemia (XLA) Cell Therapy Program

PR-M03-24-01

Clinical Trial Enrollment

NMDP Announces Enrollment of First Patient in OPTIMIZE Clinical Trial